| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | President and CEO, Director | Restricted Stock Unit | 700K | $3.47M | $4.96 | Jan 31, 2024 | Direct |
| COLLEGIUM PHARMACEUTICAL, INC | Director | Common Stock | 49.4K | $1.59M | $32.30 | May 16, 2024 | Direct |
| ZEVRA THERAPEUTICS, INC. | President and CEO, Director | Stock Option (right to buy) | 600K | Oct 10, 2023 | Direct | ||
| Adamas Pharmaceuticals Inc | Chief Executive Officer, Director | Common Stock | 0 | $5.16 | Nov 24, 2021 | Direct | |
| Adamas Pharmaceuticals Inc | Chief Executive Officer, Director | Stock Option (Right to Buy) | 0 | Nov 24, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| COLL | COLLEGIUM PHARMACEUTICAL, INC | May 16, 2024 | 1 | $0 | 4 | May 16, 2024 | Director |
| ZVRA | ZEVRA THERAPEUTICS, INC. | Jan 31, 2024 | 1 | $0 | 4 | Feb 2, 2024 | President and CEO, Director |
| ZVRA | ZEVRA THERAPEUTICS, INC. | Oct 10, 2023 | 2 | $0 | 4 | Oct 11, 2023 | President and CEO, Director |
| ZVRA | ZEVRA THERAPEUTICS, INC. | Oct 10, 2023 | 0 | $0 | 3 | Oct 10, 2023 | President and CEO, Director |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | May 18, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | May 19, 2022 | 1 | $0 | 4 | May 23, 2022 | Director |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | Apr 6, 2022 | 1 | $0 | 4 | Apr 8, 2022 | Director |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | Apr 6, 2022 | 0 | $0 | 3 | Apr 8, 2022 | Director |
| ADMS | Adamas Pharmaceuticals Inc | Nov 24, 2021 | 4 | $0 | 4 | Nov 24, 2021 | Chief Executive Officer, Director |